FB Rice

On International Equal Pay Day, we are proud to announce our commitment to closing the gap and advancing gender equality. At FB Rice, we believe gender equality is a movement that must be led. Our new parental leave policy, developed by our Inclusion and Diversity Committee, is designed to redefine traditional gender roles and support equal caregiving. Achieving equal pay is a crucial milestone in the journey toward gender equality and human rights. As we mark International Equal Pay Day, we’re proud to introduce this initiative that helps drive real change, both in our workplace and the broader community. 🎥 Watch the video below to learn how we’re championing equality, featuring insights from Madeleine Kelly, Beata Khaidurova and David Herman. 🔗 Find out more via our website: https://lnkd.in/gQFBh_sm #InternationalEqualPayDay #genderequality #equalpay #parentalleave #inclusionanddiversity #closingthegap United Nations

A round of applause for our IAM Global Leaders! Please join us in celebrating Brett Lunn, Jenny Petering, Ian Rourke, and Matt Adams for their inclusion in the IAM Global Leaders 2025 list. With only 15 leaders from Australia and 13 from New Zealand represented on this list, their achievements are especially noteworthy. This list honours top patent experts globally for their dedication, innovation, and commitment to excellence, with client experience at the forefront. We’re proud to see their hard work recognised globally – congratulations, team! 👏 #IAMGlobalLeaders #Patents #IPExperts #ClientExperience

Two weeks to go! The annual International Trademark Association (INTA) Leadership Meeting is fast approaching - Sarah Dixon, a member of the Trademark Administrators Committee, will be attending and looks forward to connecting with colleagues and other committee members.   Reach out if you’ll also be in New Orleans!

FB Rice is excited to announce our participation in the upcoming AusBiotech conference this week.    Cameron Smith, Partner in our Biotechnology team, will be chairing the Cell & Gene Summit session on Commercialisation of Cell and Gene Therapies: What Does It Take? This session will feature short pitch-style talks from industry leaders on navigating the commercialisation journey, from startup to scaleup.    Cameron will lead a conversation with an impressive panel, including: Dr Deborah Rathjen, CEO, Carina Biotech Michael Baker, CEO, Arovella Therapeutics ASX: ALA Sam Cobb, CEO, Currus Biologics Pty Ltd We are expectant of the engaging discussions and valuable insights that will emerge at the conference. #AusBiotech2024 #CellAndGeneTherapies #BiotechInnovation

We’re pleased to share that Connie Merlino, Lee Miles and Matt Adams will be attending the American Intellectual Property Law Association (AIPLA) 2024 Annual Meeting in National Harbor, MD! They are eager to engage with the global IP community, exchange insights, and explore new perspectives on the future of IP. See you at #AIPLA2024!

We’ve been fortunate to host Sabryn Hamila, PhD and Carla Andrit as part of the Australian Academy of Technological Sciences & Engineering’s (ATSE) IMNIS Ignite program. As their 6-week internships with us wrap up, Sabryn and Carla have gained valuable insights into the world of IP, guided by our partners Lee Miles and Prue Cowin, with support from our wider team. It’s been a pleasure to be part of their journey, and we look forward to following along as they take their next steps in their careers. ATSE’s IMNIS Ignite program provides an outstanding platform for connecting early-career researchers with industry, and we are proud to be part of this initiative. 👉 Find out more here: https://lnkd.in/gn_P5edm Industry Mentoring Network in STEM #Mentoring #IMNISIgnite #ATSE

Reflecting on a fantastic session last week led by Prue Cowin at BioMelbourne Network's #BioSymposium! Prue’s session explored how companies can effectively position their IP to stand out in the increasingly competitive ADC landscape. Three key takeaways from the session: 1. Big pharma partnerships are driving growth — Licensing deals continue to be bolstered by big pharma ADC collaborations 2. Stand out with a compelling investment story — Focus on compelling clinical and market need for ADC investment propositions 3. Protect your advantage — Establish a patent strategy that not only safeguards innovation but also appeals to potential collaborators and investors. A fantastic opportunity to share expertise and contribute to the #ADC conversation!

Are you attending #LSPN Fall 2024? Reach out to connect with FB Rice partners Connie Merlino and Lee Miles at the conference! They’re looking forward to engaging with innovation leaders from around the world to discuss the challenges and opportunities in leveraging IP. See you in San Francisco!

Today, on World Mental Health Day, we’re reminded that mental health matters every day. Through our Employee Assistance Program, Mental Health Officers, and regular workshops, we prioritise well-being and encourage open conversations. We were pleased to welcome back Sally Cumming, Founder of Engage Health and a “personal trainer for the mind,” who shared neuroscience-backed strategies to build mental resilience through breathwork, mindfulness, and emotional regulation. Sally also highlighted the power of gratitude, explaining how just 21 days of practice can rewire the brain for more positive emotions. Thank you, Sally, for sharing your expertise and practical tools to support our mental health—all invaluable in today’s busy world! World Health Organization (WHO) #WorldMentalHealthDay

Do you regularly review your trade mark portfolio?🔍 Regular trade mark reviews are essential for both companies and in-house attorneys. While trade marks can last for 10 years and ultimately in perpetuity if renewed, older marks can sometimes be overlooked. Sarah Dixon outlines why it's important to take the time to stay on top of your portfolio to ensure your trade marks are working for your business. #trademarks #BrandProtection #IPStrategy